Review
Fate of fat: The role of adipose triglyceride lipase in lipolysis

https://doi.org/10.1016/j.bbalip.2008.10.005Get rights and content

Abstract

Lipolysis, the coordinated catabolism of triacylglycerol (TG) stored in cellular lipid droplets, provides fatty acids, di-, and monoglycerides. These products are important energy substrates, precursors for other lipids, or lipid signaling molecules. Following their discovery by Hollenberg, C.H., Raben, M.S., and Astwood, E.B.(1961) and Vaughan, M., Berger, J.E., and Steinberg, D. (1964), hormone-sensitive lipase (HSL) and monoacylglycerol lipase stayed in the focus of research for three decades. Within the last decade, however, it became evident that the lipolytic pathway is incompletely understood. Studies on the regulation of lipolysis and the characterization of HSL-deficient mice indicated that additional previously unrecognized factors that contribute to fat catabolism must exist. This led to the discovery of the perilipin, adipophilin, Tip47 (PAT) family of lipid droplet binding proteins and the identification of a novel TG hydrolase named adipose triglyceride lipase (ATGL). This review focuses on the importance of ATGL as TG lipase within the “lipolytic machinery” and the current knowledge of molecular mechanisms that regulate ATGL activity.

Introduction

Unesterified fatty acids (FA) are biomolecules that serve multiple functions. FA represent constituents of essentially all lipid classes, regulate gene expression by acting directly or indirectly as ligands for nuclear receptors, affect protein function by post-transcriptional acylation of target peptides, and, above all, serve as the most energy-dense substrate in the body for the production of ATP. However, excessive cellular concentrations of FA are toxic to cells and tissues. Because of their amphipathic nature, FA act as detergents, damage cell and organelle membranes, and perturb the cellular acid/base homeostasis. To avoid toxicity, FA are esterified with glycerol and the resulting triacylglycerols (TG) are deposited in lipid droplets (LDs) in essentially all cells of the body. Accordingly, TG stores function as buffer for incoming lipids to prevent lipotoxic free fatty acid (FFA) concentrations [1], [2]. White adipose tissue (WAT) represents by far the most efficient organ to store excessive amounts of circulating FA during the postprandial period. At times of demand, FA are released from cellular LDs by the action of TG hydrolases, a process called lipolysis. Initially, the limited amount of lipids present in most tissues is hydrolyzed. During prolonged fasting, however, these stores are not sufficient to meet the requirements of FA for energy production and fat stores must be mobilized by the induction of lipolysis in adipocytes.

Only a carefully regulated balance of lipid synthesis and lipolysis in WAT and other tissues will maintain whole body energy homeostasis. Dysregulation of these processes may be linked to metabolic disorders like obesity, lipodystrophy, type 2 diabetes, and the metabolic syndrome [3]. Current evidence suggests that TG are hydrolyzed in a sequential process involving different lipases. ATGL and HSL are necessary for proper hydrolysis of tri- and diglycerides, respectively. The last step in lipolysis is performed by monoglyceride lipase (MGL), which hydrolyzes monoglycerides to form glycerol and fatty acids. The activity of ATGL and HSL is tightly regulated by hormones. In contrast, to our knowledge no evidence exists that MGL activity is affected by hormonal stimulation. However, in vitro experiments suggest that the enzyme is required for complete degradation of TG [4]. This review will summarize the current knowledge of function and regulation of ATGL and HSL in adipose and non-adipose tissues with a special emphasis on ATGL.

Section snippets

Lipid droplets: dynamic cellular organelles

The principal substrate for lipolytic enzymes, cellular TG, are stored in cytosolic LDs in essentially all tissues of the body. LDs exhibit a particle core composed of TG and cholesteryl esters and are surrounded by a phospholipid monolayer that contains numerous proteins with structural, regulatory or enzymatic functions [5], [6]. LD cage proteins are characterized by the presence of PAT domains in their primary sequence. The PAT domain is defined by a conserved amino acid sequence present in p

HSL

The classical and for many decades considered the only enzyme responsible for the hydrolysis of TG is HSL. Originally described in the early 60's [21], [22], HSL was shown to exhibit broad substrate specificity capable of hydrolyzing cholesterylester, tri-, di-, and monoacylglycerol (TG, DG and MG), retinyl ester, and numerous water soluble ester substrates [23], [24]. The enzyme is most active against DG which is hydrolyzed ∼ 10 fold faster than TG. For decades, it was assumed that HSL is the

ATGL

In 2004, three groups independently reported an enzyme capable of hydrolyzing TG. The TG hydrolase was named adipose triglyceride lipase (ATGL) [35], desnutrin [36], or phospholipase A2ξ [37]. ATGL is highly expressed in adipose tissue and its expression markedly increases during 3T3-L1 adipocyte differentiation [35], [36], [38], [39]. ATGL expression is also observed in cardiac muscle [40], type I fibers of skeletal muscle [41], testis, macrophages (unpublished observation), liver [42], and

ATGL deficiency in mice

The important role of ATGL in lipolysis became evident when parameters of lipid and energy metabolism were analyzed in ATGL-deficient (ATGL-ko) mice [40]. In contrast to HSL-deficient mice exhibiting decreased fat mass, ATGL-ko animals had enlarged fat depots and the TG hydrolase activities in WAT lysates were drastically reduced (∼ 80%). ATGL-deficiency decreased the release of FA from WAT by ∼ 70% in response to isoproterenol treatment and this decreased lipolytic rate resulted in substantially

ATGL deficiency in humans

Recently, mutations in the human ATGL gene were described that are associated with functional defects of the enzyme and the accumulation of lipids in multiple tissues [45], [46], [47]. Currently, only five individuals affected with this autosomal recessive disorder have been described. According to Fischer et al. [45], the human condition of ATGL deficiency is named Neutral Lipid Storage Disease with myopathy (NLSDM). In addition to the systemic TG accumulation, patients invariably suffer from

ATGL regulation: ATGL activity is “hormone-sensitive”

Experiments in HSL-deficient adipose tissue showed that the remnant lipolytic activity can be activated by β-adrenergic stimulation [28], [52]. Already before the discovery of ATGL, this observation suggested that the non-HSL activity is “hormone-sensitive”. With the discovery of ATGL and the availability of ATGL-ko mice it became evident that ATGL activity is stimulated by isoproterenol and inhibited by insulin. The mechanisms how hormones affect ATGL enzyme action require better

ATGL regulation: CGI-58

In 2006, Lass et al. [60] showed that ATGL activity is strongly stimulated by an activator protein annotated as α/β hydrolase domain containing protein 5 [ABHD5; also known as comparative gene identification-58 (CGI-58)]. Mouse ATGL is up to 20-fold more active in the presence of CGI-58. Human CGI-58 also activates human ATGL although the magnitude of activation is less pronounced (∼ 5-fold). The finding that ATGL requires a coactivator is not unexpected because several other TG hydrolases that

Molecular mechanisms regulating lipolysis

Studies in perilipin-deficient mice [64], [65] and in vitro experiments [7], [8], [9] indicated a dual role for perilipin in lipolysis: Under basal, non-hormone stimulated conditions, perilipin protects the LD from lipolysis, whereas in stimulated cells phosphorylated perilipin facilitates lipid degradation. The molecular basis of HSL activation is its translocation from the cytosol to the lipid droplet in response to hormonal stimulation and perilipin is essential for the translocation

Regulation of ATGL in non-adipose tissues

Although the reversible interaction of CGI-58 with perilipin represents a potential regulatory event in adipocytes, many aspects of ATGL regulation remain unclear. First, this mechanism is restricted to perilipin expressing cells and tissues such as adipose tissue and adrenals. However, it is well established that ATGL and CGI-58 also play an important role in other tissues such as muscle and liver, which do not express perilipin. Thus, additional mechanisms must exist that regulate ATGL

Conclusion

Data from ATGL-deficient mice and humans with mutations in PNPLA2, the gene coding for ATGL assign a central role to this enzyme for the catabolism of cellular fat stores.

Do we now understand lipolysis? No. Despite the discovery of ATGL and its activator as well as the elucidation of the role of certain PAT proteins in lipolysis, numerous issues remain unsettled. I) The regulation and function of ATGL and CGI-58 are incompletely understood. Currently it is unknown how phosphorylation affects

Acknowledgements

This research was supported by the grants SFB LIPOTOX F30 and P18434-B05 which are funded by the Austrian Fonds zur Förderung der wissenschaftlichen Forschung (FWF) and ''GOLD – Genomics of Lipid-Associated Disorders'', which is part of the Austrian Genome Project ''GEN-AU Genome research in Austria'' funded by the Austrian Ministry for Science and Research (BMWF) and the Austrian Forschungsförderungsgesellschaft FFG.

References (78)

  • M. Lafontan et al.

    Control of lipolysis by natriuretic peptides and cyclic GMP

    Trends Endocrinol. Metab.

    (2008)
  • M. Vaughan et al.

    Hormone-sensitive lipase and monoglyceride lipase activities in adipose tissue

    J. Biol. Chem.

    (1964)
  • S.J. Yeaman et al.

    The multifunctional role of hormone-sensitive lipase in lipid metabolism

    Adv. Enzyme Regul.

    (1994)
  • G. Fredrikson et al.

    Hormone-sensitive lipase of rat adipose tissue. Purification and some properties

    J. Biol. Chem.

    (1981)
  • A.H. Hirsch et al.

    Lipolytic stimulation modulates the subcellular distribution of hormone-sensitive lipase in 3T3-L1 cells

    J. Lipid Res.

    (1984)
  • A.S. Greenberg et al.

    Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets

    J. Biol. Chem.

    (1991)
  • G. Haemmerle et al.

    Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis

    J. Biol. Chem.

    (2002)
  • R. Zimmermann et al.

    Decreased fatty acid esterification compensates for the reduced lipolytic activity in hormone-sensitive lipase-deficient white adipose tissue

    J. Lipid Res.

    (2003)
  • S. Cinti et al.

    Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans,

    J. Lipid Res.

    (2005)
  • J.A. Villena et al.

    Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis

    J. Biol. Chem.

    (2004)
  • C.M. Jenkins et al.

    Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities

    J. Biol. Chem.

    (2004)
  • B.N. Reid et al.

    Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis

    J. Biol. Chem.

    (2008)
  • M. Schweiger et al.

    The C-terminal region of human adipose triglyceride lipase affects enzyme activity and lipid droplet binding

    J. Biol. Chem.

    (2008)
  • S. Kralisch et al.

    Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes

    Mol. Cell. Endocrinol.

    (2005)
  • J.W. Jocken et al.

    Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity

    Physiol. Behav.

    (2008)
  • C. Chung et al.

    Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL)

    J. Hepatol.

    (2008)
  • L. Notari et al.

    Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor

    J. Biol. Chem.

    (2006)
  • A. Lass et al.

    Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin–Dorfman Syndrome

    Cell. Metab.

    (2006)
  • C. Lefevre et al.

    Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin–Dorfman Syndrome

    Am. J. Hum. Genet.

    (2001)
  • A.K. Ghosh et al.

    CGI-58, the causative gene for Chanarin–Dorfman Syndrome, mediates acylation of lysophosphatidic acid

    J. Biol. Chem.

    (2008)
  • J.G. Granneman et al.

    Analysis of lipolytic protein trafficking and interactions in adipocytes

    J. Biol. Chem.

    (2007)
  • C.L. Su et al.

    Mutational analysis of the hormone-sensitive lipase translocation reaction in adipocytes

    J. Biol. Chem.

    (2003)
  • H. Miyoshi et al.

    Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanisms

    J. Biol. Chem.

    (2006)
  • H. Miyoshi et al.

    Control of adipose triglyceride lipase action by serine 517 of perilipin A globally regulates protein kinase A-stimulated lipolysis in adipocytes

    J. Biol. Chem.

    (2007)
  • T. Yamaguchi et al.

    CGI-58 interacts with perilipin and is localized to lipid droplets. Possible involvement of CGI-58 mislocalization in Chanarin–Dorfman Syndrome

    J. Biol. Chem.

    (2004)
  • V. Subramanian et al.

    Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes

    J. Biol. Chem.

    (2004)
  • A. Marcinkiewicz et al.

    The phosphorylation of serine 492 of perilipin A directs lipid droplet fragmentation and dispersion

    J. Biol. Chem.

    (2006)
  • L.L. Listenberger et al.

    Adipocyte differentiation-related protein reduces the lipid droplet association of adipose triglyceride lipase and slows triacylglycerol turnover

    J. Lipid Res.

    (2007)
  • R.H. Unger

    Lipotoxic diseases

    Annu. Rev. Med.

    (2002)
  • Cited by (190)

    View all citing articles on Scopus
    View full text